Arcellx (ACLX) Cash from Investing Activities (2021 - 2025)

Arcellx (ACLX) recorded quarterly Cash from Investing Activities of $57.8 million in Q4 2025, up 388.61% quarter-over-quarter from -$20.0 million in Q3 2025, and up 1502.86% on a YoY basis from $3.6 million in Q4 2024.

Arcellx (ACLX) Cash from Investing Activities (2021 - 2025) Analysis & Trends

Arcellx's Cash from Investing Activities history runs 5 years deep, the most recent figure standing at $57.8 million for Q4 2025.

  • In Q4 2025, Cash from Investing Activities rose 1502.86% year-over-year to $57.8 million; the TTM figure through Dec 2025 stood at $86.3 million (up 147.15% YoY), while the FY2025 annual figure was $86.3 million, up 147.15% from the prior year.
  • Cash from Investing Activities was $57.8 million for Q4 2025 at Arcellx, up from -$20.0 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $57.8 million in Q4 2025 to a low of -$206.8 million in Q1 2024.
  • Historically, Cash from Investing Activities has averaged -$22.4 million across 5 years, with a median of -$6.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities sank 32807.22% in 2022, then soared 1502.86% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$17.7 million in 2021, then jumped by 290.35% to $33.6 million in 2022, then plunged by 37.49% to $21.0 million in 2023, then sank by 119.6% to -$4.1 million in 2024, then surged by 1502.86% to $57.8 million in 2025.
  • The last three Cash from Investing Activities figures came in at $57.8 million (Q4 2025), -$20.0 million (Q3 2025), and $10.7 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Arcellx 6.48 Bn 6.48 Bn - 57.80 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 57.80 Mn
Dec 31, 2025 57.80 Mn
Sep 30, 2025 -20.03 Mn
Sep 30, 2025 -20.03 Mn
Jun 30, 2025 10.74 Mn
Jun 30, 2025 10.74 Mn
Mar 31, 2025 37.78 Mn
Mar 31, 2025 37.78 Mn
Dec 31, 2024 -4.12 Mn
Dec 31, 2024 -4.12 Mn
Sep 30, 2024 35.76 Mn
Sep 30, 2024 35.76 Mn
Jun 30, 2024 -7.87 Mn
Jun 30, 2024 -7.87 Mn
Mar 31, 2024 -206.81 Mn
Mar 31, 2024 -206.81 Mn
Dec 31, 2023 21.02 Mn
Dec 31, 2023 21.02 Mn
Sep 30, 2023 -160.03 Mn
Sep 30, 2023 -160.03 Mn